Prof. Dr. Christian Gratzke has held the professorship for urology at the medical faculty of the University of Freiburg since November 2018 and is also the medical director of the clinic for urology. Prof. Gratzke studied human medicine in Munich and Vienna. He completed his specialist training at the Ludwig-Maximilians-University in Munich, where he also habilitated and most recently worked as senior consultant in urology. The clinical focus of Prof. Christian Gratzke includes the diagnosis and therapy of prostate carcinoma and benign prostate enlargement. The focus is on new, minimally invasive techniques such as robot-assisted, laparoscopic surgery on the prostate and kidneys.
Selected publications from PubMed
Differences in Perioperative, Postoperative, Histological, and Early Functional Outcomes during Curricular and Non-Curricular Training for Robot-Assisted Radical Prostatectomy: A One-To-One Surgeon Comparison.
Liakos N, Grabbert M, Pyrgidis N, Gratzke C, Wagner C, Bockelmann D
Urol Int. 2026 Aug 28;:1 doi: 10.1159/uin/aewag009.
Spatial Distribution of Prostate Cancer Missed by MRI-Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort.
Himmelsbach R, Franz J, Jilg C, Gratzke C, Sigle A
Prostate. 2026 Aug;86(11):1216-1223 doi: 10.1002/pros.70201.
Repeated Renal Interventions for Renal Cell Carcinoma in von Hippel-Lindau Disease: Long-Term Outcomes.
Jilg CA, Astheimer SC, Kotsis F, Ganner A, Schultze-Seemann W, Neumann HP, Grabbert MT, Spohn S, Kirste S, Gratzke C, Neumann-Haefelin E, Himmelsbach R
Eur Urol Focus. 2026 Jul 31 pii: S2405-4569(26)00148-3. doi: 10.1016/j.euf.2026.07.002.
Structured robotic surgery training in Germany: a five-year evaluation of the German curriculum for robot-assisted radical prostatectomy.
Handke A, Wagner C, Liakos N, Janssen M, Kayaci-Güner Ö, Grabbert M, Haas M, Bründl J, Ubrig B, Siemer S, Gratzke C, Moritz R, Handke A, German Society of roboter-assistied Urology and the Working Group for Laparoscopics and Robotics of the Germany Society of Urology
J Robot Surg. 2026 Jul 20;20(1) pii: 647. doi: 10.1007/s11701-026-03638-5.
ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT.
Franz J, Brumberg J, Mix M, Meyer PT, Herrmann K, Gratzke C, Sigle A
Eur Urol Focus. 2026 Jul 15 pii: S2405-4569(26)00119-7. doi: 10.1016/j.euf.2026.06.023.
Help your network discover Dr. Christian Gratzke's clinical expertise.
